SIO_812200-22_AM_BannerUpdates_728x90.jpg

SIO2022 Technology Pass Session Offerings

The Society of Interventional Oncology is offering a brand new "Technology Pass" to individuals who are unable to attend the in-person meeting in San Francisco. The Technology Pass offers remote attendees access to all live-streamed sessions during the SIO2022 Annual Scientific Meeting. See below for Technology Pass sessions included in the price of registration. 

Please email info@sio-central.org with any questions regarding the SIO2022 Technology Pass.

Purchase Your Technology Pass Today

All Levels
100 Level 
200 Level
300 Level

*The session information listed here is subject to change. This page was last updated 8 February 2022. 

Friday, 25 March 2022

Time (PST)

Session Title(s)

7:45am - 9:00am 

Welcome and Dr. Sidney Wallace and Dr. Michael J. Wallace Distinguished Lecture

Riad Salem, MD, MBA, Northwestern University, USA

9:00am - 10:30am

HCC

Moderators: Isabel Newton, MD, PhD, VA San Diego Healthcare System and UC San Diego, USA; David Breen, MD, University Hospital Southampton, UK 

  • Changing Landscape of Systemic Therapies for HCC, John Gordan, MD, UCSF, USA
  • LIRADS: Therapeutic response, Yuko Kono, MD, PhD, UCSD, USA
  • Harnessing Tumor Metabolism to Overcome Loco-regional Therapy Failures, Terence Gade, MD, PhD, Penn Image-Guided Interventions Lab, University of Pennsylvania, USA
  • Compete or Combine: Lessons from the Imbrave-150 trial, Riccardo Lencioni, MD, University of Pisa School of Medicine, Italy
  • Beyond the Algorithm: How to choose the best LRT, Nadine Abi Jaoudeh, MD, FSIR, CCRP, University of California Irvine, USA
  • Evolution of Radioembolization in HCC: Big doses, small placesRobert Lewandowski, MD, FSIR, Northwestern Medicine, USA
  • Latest Trends in Ablation, Laura Crocetti, Prof., MD, PhD, University of Pisa School of Medicine, Italy
10:30am - 10:40am

Ethics of Consent in IR

Presented in partnership with The Interventional Initiative

  • Patient Decision Aids to Improve Patient Care in IO, Eric Keller, MD, MA, Stanford University, USA

11:00am - 12:00pm

Pain Palliation

Moderators: Sean Tutton, MD, FSIR, FCIRSE, UCSD, USA; Dimitrios Filippiadis, University of Athens, Greece

  • Pharmacological Management of Cancer Pain in 2022, Paul Lindenfeld, MD, UCSF, USA
  • Nerve Blocks and Steroid Injections for Cancer Pain, Dan Nguyen, MD, Neuroradiology & Pain Solutions of Oklahoma, USA
  • Percutaneous Neurolysis in 2022: Facing the challenges, J. David Prologo, MD, FSIR, ABOM-D, Emory University School of Medicine, USA
  • Multidisciplinary Approach to Cancer Pain with Combination Treatment, Sean Tutton, MD, FSIR, FCIRSE, UCSD, USA
  • The Role of Percutaneous Ablation in the Palliation of Cancer Pain, Alan Sag, MD, Duke University Medical Center, USA

Complex Cases

Moderators: Edward Kim, MD, Mount Sinai Health Systems, USA; Matthew Callstrom, MD, PhD, Mayo Clinic, USA; Stephen Solomon, MD, Memorial Sloan Kettering Cancer Center, USA

Moderators will bring cases for discussion.

12:30pm - 1:15pm

Industry Symposium

IO Clinical Trials: Essential recent data for the IR

Presented by Boston Scientific Corporation

1:25pm - 2:10pm

Industry Symposium

Presented by TriSalus

2:20pm - 3:50pm

Controversies

ModeratorsDavid Breen, MD, University Hospital Southampton, UK; William Rilling, MD, FSIR, Medical College Wisconsin, USA

  • Painful Pelvic Metastasis: Radiotherapy or ablation?, A. Nick Kurup, MD, Associate Professor of Radiology, Mayo Clinic, USA v. Mary Feng, MD, UCSF, USA
  • PVE vs. Double Venous Deprivation: Why?, Daniel Brown, MD, Vanderbilt University Medical Center, USA v. Alban Denys, Pr. CHUV University of Lausanne, USA
  • Peripheral Colorectal Lung Mets: SBRT vs. ablation, Thierry de Baere, MD, Gustave Roussy, France v. Abraham Wu, MD, Memorial Sloan Kettering Cancer Center, USA
  • Intermediate HCC: The shifting TACE and systemic therapy interface, Robert Lewandowski, MD, FSIR, Northwestern Medicine, USA, v. Laura Crocetti, Prof., MD, PhD, University of Pisa School of Medicine, Italy
4:00pm - 5:00pm

HCC Tumor Board

Moderators: Robert Lewandowski, MD, FSIR, Northwestern Medicine, USA; Isabel Newton, MD, PhD, VA San Diego Healthcare System and UC San Diego, USA 

Case Discussions:

  • John Gordan, MD, UCSF, USA
  • Nadine Abi Jaoudeh, MD, FSIR, CCRP, University of California Irvine, USA
  • Laura Crocetti, Prof., MD, PhD, University of Pisa School of Medicine, Italy
  • William Rilling, MD, FSIR, Medical College Wisconsin, USA
  • Mary Feng, MD, UCSF, USA
  • Additional faculty TBD
5:15pm - 6:15pm

Scientific Oral Abstract Presentations

ModeratorsDamian Dupuy, MD, FACR, Cape Cod Hospital, USA; Bradford Wood, MD, National Institutes of Health, USA

  • 3D Quantitative Ablation Margins for Prediction of Ablation Site Recurrence After Stereotactic Image-guided Microwave Ablation of Colorectal Liver, Simeon Ruiter, MSc, University Medical Center Groningen, Netherlands
  • A Randomized, Open-label, International, Multicenter, Phase 3 Trial of Radioembolization with Chemotherapy for Colorectal Liver Metastases: The EPOCHRobert Lewandowski, MD, FSIR, Northwestern Medicine, USA
  • Y90 Radiation Segmentectomy of HCC: A Comparative Study of Effectiveness, Safety and Dosimetry of Glass vs. Resin-based Microspheres, Alexander Villalobos, MD, Emory University School of Medicine, USA
  • Lymphatic Embolization vs. Sclerotherapy in Management of Iatrogenic Lymphoceles after Oncological Surgery, Ahmed Aly, MB, BCh, Memorial Sloan Kettering Cancer Center, USA
  • Characterizing Combined Hepatocellular Cholangiocarcinoma in Patients Who Have Undergone Treatment With Locoregional Therapies, Anusha Naik, BS, University of Pennsylvania, USA
  • Percutaneous Microwave Ablation for Soft Tissue Retroperitoneal Tumors, Annika Rossebo, University of Wisconsin - Madison, USA
  • The Role of a Navigational Radiofrequency Ablation Device and Concurrent Vertebral Augmentation for Treatment of Difficult-to-reach Spinal Metastases, Claudio Pusceddu, MD, Oncological and Interventional Radiology Departement ARNAS, Italy

Saturday, 26 March 2022

Time (PST)

Session Title(s)

7:15am - 8:00am

Industry Symposium

Presented by IceCure

8:30am - 9:30am

Immuno Oncology

Moderators: Muneeb Ahmed, MD, Beth Israel Deaconess Medical Center/Harvard, USA; S. Nahum Goldberg, MS, FSIR, Hadassah Hebrew University Medical Center, Israel

  • Immuno Oncology: Checkpoint inhibitors and beyond, Antonia Digklia, MD, MSc, Centre Hospitalier Universitaire Vaudoise CHUV, Switzerland
  • Role of IO in Immuno Oncology, Erica Alexander, MD, Memorial Sloan Kettering Cancer Center, USA
  • Manipulating the Tumor Microenvironment, Alda Tam, MD, MD Anderson Cancer Center, USA
  • Imaging the Immune Response, Jessica Santana, PhD Student, Yale University, USA
  • Immunoadjuvants: The role of percutaneous delivery, Rahul Sheth, MD, MD Anderson Cancer Center, USA
9:50am - 10:50am 

Applied Immuno Oncology

Moderators: Stephen Hunt, MTR, MD, PhD, University of Pennsylvania, USA; Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center, USA

  • Immunomodulation in TACE SettingsStephen Hunt, MTR, MD, PhD, University of Pennsylvania, USA
  • IRE to Improve Tumor Microenvironments and Checkpoint Sensitivity in Pancreatic Cancer, Jayanth Shankara Narayanan, PhD, UCSD, USA
  • IA CAR T-cell in Metastatic Colorectal Disease, Gregory Nadolski, MD, University of Pennsylvania, USA
  • Bench to Bedside: Liver, Muneeb Ahmed, MD, Beth Israel Deaconess Medical Center/Harvard, USA
  • Q&A, All faculty

Getting Started

Moderators: David Breen, MD, University Hospital Southampton, UK; Jack Jennings, MD, PhD, Washington University, USA

  • IRE, Ronald Arellano, MD, Massachusetts General Hospital, USA
  • Chemosaturation, Brian Stedman, Consultant Interventional Radiologist, University Hospital Southampton, UK
  • Injectable Intra-tumoral Treatments, Rahul Sheth, MD, MD Anderson Cancer Center, USA
  • Cementoplasty, Francois H. Cornelis, MD, PhD, Memorial Sloan Kettering Cancer Center, USA
  • Problem Lymph Node Ablations, Philippe Pereira, MD, SLK Kliniken, Germany
  • Thyroid Ablation, Laura Crocetti, Prof., MD, PhD, University of Pisa School of Medicine, Italy
11:20am - 12:20pm

Pancreaticobiliary

Moderators: Sarah White, Medical College of Wisconsin, USA; Rony Avritscher, University of Texas MD Anderson Cancer Center, USA

  • Advances in Pancreatic Cancer Treatment: A surgeon's perspective, Flavio Rocha, Oregon Health and Science University, USA
  • Local Interventions for Advanced Pancreatic Carcinoma in the Era of Immunotherapy, Martijn Meijerink, Amsterdam UMC, Netherlands
  • Cholangiocarcinoma: An overview of novel actionable mutations, Bruno Odisio, The University of Texas MD Anderson Cancer Center, USA
  • Is TARE Superior to TACE for Unresectable Cholangiocarcinoma: An in-depth analysis, Christina Mosconi, IRCCS, Policlinico Sant’orsola Hospital, Italy
  • Palliative Treatment with Radiation-emitting Metallic Stents in Unresectable Hilar Cholangiocarcinoma, Gao-Jun Teng, Department of Interventional Radiology & Vascular Surgery, Zhongda Hospital, Southeast University, China

MSK Mets

Moderator: Matthew Callstrom, MD, PhD, Mayo Clinic, USA

  • Bone and Soft Tissue Biopsies of Metastatic Disease: Tips and tricks for the challenging cases, Travis Hillen, MD, Washington University School of Medicine St. Louis, USA
  • Treatment of Pathologic Fractures of the Spine: Vertebral augmentation from cement to implants, Alexis Kelekis, MD, PhD, EBIR, FCIRSE, FSIR, National and Kapodistrian University of Athens, Greece
  • The Role of Bone Ablation for Local Tumor Control, Lindsay Stratchko, DO, University of Wisconsin, USA
  • Treatment of Extra-spinal Pathologic Fractures: Percutaneous osteoplasty from cement to screws and implants, Frederic Deschamps, MD, PhD, Gustave Roussy, France
  • Complications of Percutaneous Ablation: How to minimize and avoid, Matthew Callstrom, MD, PhD, Mayo Clinic, USA
12:30pm - 1:15pm

Industry Symposium

Presented by Sirtex

1:25pm - 2:10pm

Industry Symposium

New Advances in Catheter-directed Therapy

Moderators: Michael Soulen, MD, FSIR, FCIRSE, Abramson Cancer Center, University of Pennsylvania, USA; Nicholas Fidelman, MD, UCSF, USA

  • Bronchial Artery Chemoembolization, Ed Boas, City of Hope Cancer Center, USA
  • Embolization for Renal Cell Carcinoma, Michael Soulen, MD, FSIR, FCIRSE, Abramson Cancer Center, University of Pennsylvania, USA
  • Chemoembolization for Head and Neck Tumors, Kazim Narsinh, MD, UCSF, USA

2:20pm - 3:50pm

mCRC

Moderators: Costi Sofocleous, MD, PhD, Weill-Cornell Medical College/Memorial Sloan Kettering Cancer Center, USA; William Rilling, MD, FSIR, Medical College Wisconsin, USA

  • Actionable Mutations: The geography of mCRC, Antonia Digklia, MD, MSc, Centre Hospitalier Universitaire Vaudoise CHUV, Switzerland
  • Vanishing Metastases: Resect, ablate, wait?, Martijn Meijerink, MD, PhD, Amsterdam UMC, Netherlands
  • Is Surgical Wedge Resection Still the Gold Standard?, Eric Nakakura, MD, UCSF, USA
  • Ablation of mCRC: Effectiveness?, Costi Sofocleous, MD, PhD, Weill-Cornell Medical College/Memorial Sloan Kettering Cancer Center, USA
  • FLR Assessment: How to, David Madoff, MD, Yale School of Medicine, USA 
  • Double Venous Deprivation: Really?, Boris Guiu, MD, PhD, Montpellier University Hospital, France
  • Radioembolization: Current best utilization, Daniel Brown, MD, Vanderbilt University Medical Center, USA
4:00pm - 5:00pm

SIO Meets KSIR: Current Status of Interventional Treatment of HCC in Korea

Moderators: Chang Won Kim, KSIR Vice President, Pusan National University, Korea; Uei Pua, MBBS, Tan Tock Seng Hospital, Singapore

  • Introduction to KSIRChang Won Kim, KSIR Vice President, Pusan National University, Korea
  • Chemoembolization, In Joon Lee, MD, PhD, National Cancer Center, Korea
  • Radioembolization, Hyo-Cheol Kim, PhD, Seoul National University Hospital, Korea
  • Ablation Therapy, Dong Ho Lee, MD, MS, Seoul National University Hospital, Korea

mCRC Tumor Board

Moderators: Costi Sofocleous, MD, PhD, Weill-Cornell Medical College/Memorial Sloan Kettering Cancer Center, USAWilliam Rilling, MD, FSIR, Medical College Wisconsin, USA

Case Discussions:

  • Eric Nakakura, MD, UCSF, USA
  • Daniel Brown, MD, Vanderbilt University Medical Center, USA
  • Nicholas Fidelman, MD, UCSF, USA
  • Mary Feng, MD, UCSF, USA
  • Chloe Atreya, MD, PhD, UCSF, USA
5:15pm - 6:15pm

Scientific Oral Abstracts - SIO Debut Presentations

ModeratorsWilliam Rilling, MD, FSIR, Medical College Wisconsin, USA; Dimitrios Filippiadis, University of Athens, Greece

  • Prospective Study on the Immunological Effects of Conventional Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: An interim analysis, Robin Schmidt, Department of Radiology, Charité Virchow Klinikum, Germany
  • Virtual Platform for Assessing Liver Tumor Ablation Margin: Microwave Ablation vs. Intravascular Plasmonic Photothermal Ablation, Mir Hadi Razeghi Kondelaji, MSc, Medical College of Wisconsin, USA
  • Improved Outcomes of Thermal Ablation for Colorectal Liver Metastases: A 10-year analysis from the prospective of Amsterdam CORE registry (AmCORE), Robbert S. Puijk, MD, Amsterdam University Medical Centers, VU Medical Center Amsterdam
  • Long-term Outcome After Thermal Ablation for Renal Cancer in the Non-elderly, Healthy Population, Wenhui Zhou, MD, PhD, Stanford University, USA
  • Real-time PET Improves Tumor Detection and Ablation Margin Calculation When Used in Combination with CT-guided Ablation of Colorectal Liver Metastases, Mahdi Zirakchian Zadeh, MD, Memorial Sloan Kettering, USA
  • Hepatic and Renal Histotripsy in an Anticoagulated Swine Model, Scott Mauch, MD, University of Wisconsin, USA
  • Percutaneous Vesselplasty in Osteolytic Primary or Secondary Vertebral Lesions After the Radiofrequency Ablation: Safety and Efficacy, Chiara Zini, MD, PhD, Azienda Ospedaliera Universitaria Senese, Italy

Sunday, 27 March 2022

Time (PST)

Session Title(s)

7:15am - 8:00am

MR Lymphangiography and Lymphatic Interventions

Maxim Itkin, MD, Penn Medicine, USA

8:30am - 9:30am

AI

Moderator: Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center, USA

  • What is AI?, Krishna Nand Keshava Murthy, PhD, Memorial Sloan Kettering Cancer Center, USA
  • AI Problems and Direction of Travel, Julius Chapiro, MD, PhD, Assistant Professor of Radiology and Biomedical Imaging, Interventional Oncology Lab, Yale University School of Medicine, USA
  • Using Deep Learning to Address the Response to Image-guided Intervention,TBD
  • Working with Industry to Facilitate AI Research, Thomas Clozel, MD, Owkin, USA
  • Implementing AI into Your IR Practice, Dania Daye, MD, PhD, Massachusetts General Hospital/Harvard Medical School, USA

Lung

Moderator: Damian Dupuy, MD, FACR, Cape Cod Hospital, USA

  • Updates on Lung Cancer Surgery, Jay M. Lee, MD, Chief Division of Thoracic Surgery, UCLA Health, USA
  • Imaging Evaluation Workup Pre- and Post-ablation, Florian J. Fintelmann, MD, Massachusetts General Hospital, USA
  • When SBRT and When Not for Lung Tumors?, Andreas Rimner, Associate Attending, Director of Thoracic Radiation Oncology Research, Memorial Sloan Kettering Cancer Center, USA
  • Current State of Interventional Pulmonology and Early Stage Lung Cancer, Eric J. Seeley, MD, UCSF, USA
  • Current Guidelines for NSCLC and Oligometastatic Disease to the Lungs, Scott J. Genshaft, MD, UCLA, USA
  • Combination Approach to Treating Lung Cancer Patients, Damian Dupuy, MD, FACR, Cape Cod Hospital, USA
9:50am - 10:50am

Breaking Ground

Moderators: Sarah White, MD, MS, Medical College of Wisconsin, USA; Stephen Solomon, MD, Memorial Sloan Kettering Cancer Center, USA

  • Pediatric Liver IO, Allison Aguado, MD, Nemours Children's Hospital, Delaware, USA
  • Breast IO: Where are we?, Yolanda Bryce, MD, Memorial Sloan Kettering Cancer Center, USA
  • Initiating MR-guided programs, David Woodrum, MD, PhD, Mayo Clinic, USA

Midgut mNET with NANETS

Moderators: Rony Avritscher, MD, University of Texas MD Anderson Cancer Center, USA; Michael Soulen, MD, FSIR, FCIRSE, Abramson Cancer Center, University of Pennsylvania, USA

  • Medical and Surgical Therapy Landscape for Well-differentiated NET Liver Metastases in 2022, Emily Bergsland, MD, UCSF, USA
  • Peptide Receptor Radionuclide Therapy: A primer for interventional radiologists, Ghassan El-Haddad, MD, Moffitt Cancer Center and Research Institute, USA
  • Liver-directed Therapy Before and After PRRT, Nicholas Fidelman, MD, UCSF, USA
  • Radioembolization in the Era of PRRT, Etay Ziv, MD, PhD, Memorial Sloan Kettering Cancer Center, USA
  • Staying Out of Trouble: Tips for prevention of carcinoid crisis and other hormone-mediated side effects, Rony Avritscher, MD, University of Texas MD Anderson Cancer Center, USA
11:20am - 12:20pm

MSK Sarcoma

Moderator: Jack Jennings, MD, PhD, Washington University, USA

  • Combining Systemic and Local Therapy for Sarcoma MSK Metasteses, Brian Schulte, MD, UCSF, USA
  • Ablation and Other Palliative Techniques for Painful Sarcoma Lesions, Roberto Luigi Cazzato, Associate Professor, University Hospital of Strasbourg, France
  • Percutaneous Ablation in Oligometastatic MSK Sarcoma for Local Tumor Control, Jack Jennings, MD, PhD, Washington University, USA
  • Percutaneous Ablation for Desmoids: What is the evidence?, Afshin Gangi, MD, University Hospital of Strasbourg, France/King’s College London, UK
  • What is the Role of HIFU for the Treatment of Sarcomas and Desmoids?, Karun Sharma, MD, PhD, Children's National Hospital & George Washington University, USA

Residents to Experts

Moderators: Vijay Ramalingam, MD, Beth Israel Deaconess Medical Center, USA; Evan Lehrman, MD, FSIR, UCSF, USA; Sarah White, MD, MS, Medical College of Wisconsin, USA; David Breen, MD, University Hospital Southampton, USA

  • Direct RFA of Portal Vein Tumor Thrombus in Continuity with HCC, Ioanna Thanou, Resident, Sotiria General Hospital of Athens, Greece
  • Siatico-Neoplastic Balloon Adhesioplasty Enabling Limb-sparing Tumor Cryoablation, Matthew Ramsay, IR Fellow, Duke University Medical Center, USA
  • Embolization of Large Arterio-bronchial Fistula Due to Metastatic Breast Cancer, Jonathon Weber, MD, University of Kentucky, USA
  • Inoperable Tumor-induced Osteomalacia, Hoowan Lee, MD, National Institutes of Health Intramural Research Program, USA
  • IO for Complex HCC, Lynne Martin, IR/DR PGY5, Stanford University, USA
12:30pm - 1:15pm

Industry Symposium

Presented by Guerbet

1:25pm - 2:10pm

Industry Symposium

Presented by HistoSonics

2:20pm - 3:50pm

Lung Mini Master Class

Moderator: Robert Suh, Clinical Professor, Radiological Sciences, David Geffen School of Medicine at UCLA, USA

  • Complication: Great saves, Robert Suh, Clinical Professor, Radiological Sciences, David Geffen School of Medicine at UCLA, USA
  • Complication: Disasters, Fereidoun Abtin, MD, UCLA Medical Center, USA
  • Biopsy and Ablation: Simultaneous and sequential best techniques, Thierry de Baere, MD, Gustave Roussy, France
  • Freeze: When, why, and where?, Peter John Littrup, MD, Ascension Providence Rochester Hospital, USA
  • Burn: When, why, and where?, Stephen Solomon, MD, Memorial Sloan Kettering Cancer Center, USA

Optimized TACE Mini Master Class

Moderators: Michael Soulen, MD, FSIR, FCIRSE, Abramson Cancer Center, University of Pennsylvania, USA; Sarah White, MD, MS, Medical College Wisconsin, USA; Nishita Kothary, MBBS, FSIR, Stanford University, USA

  • Optimal Preparation and Treatment Endpoints in cTACE, Sarah White, MD, MS, Medical College Wisconsin, USA
  • Drug Recommendations for TACE, R. Peter Lokken, MD, MPH, FSIR, UCSF, USA
  • How to Improve Local Tumor Control in Super-selective cTACE, Toshihiro Tanaka, Tokyo Medical and Dental University, Japan
  • Determining the Ideal Bead Size for EmbolizationJoseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center, USA
  • TACE via Extrahepatic Collaterals: Safety considerations, Kristen Lee, MD, Singapore General Hospital, Singapore
  • Hands-on Equipment Showcase, All panelists
4:00pm - 5:00pm

"How I Do It" Video Session

Moderators: Vijay Ramalingam, MD, Beth Israel Deaconess Medical Center, USA; Steven Yevich, MD, MPH, University of Texas MD Anderson Cancer Center, USA

  • Complex Pelvic Instrumentation, Frederic Deschamps, MD, PhD, Gustave Roussy, France
  • Lymphatic Intervention, Gregory Nadolski, MD, University of Pennsylvania, USA
  • Venous Intervention for Palliation in SVC Syndrome/Lower Extremity EdemaEvan Lehrman, MD, FSIR, UCSF, USA
  • Complex Renal Cryoablation (T1B > 4 cm), Ryan Michael Kohlbrenner, MD, UCSF, USA
  • Chemosaturation, Brian Stedman, Consultant Interventional Radiologist, University Hospital Southampton, UK

Meet the Researchers Forum

Moderators: Alda Tam, MD, MD Anderson Cancer Center, USA; Michael Soulen, MD, FSIR, FCIRSE, Abramson Cancer Center, University of Pennsylvania, USA 

  • RETNET (Neuroendocrine carcinoma, cTACE vs. bland embolization), Michael Soulen, MD, FSIR, FCIRSE, Abramson Cancer Center, University of Pennsylvania, USA
  • COLLISION Trial (Colorectal ablation vs surgery), Martijn Meijerink, MD, PhD, Amsterdam UMC, Netherlands
  • COVERALL Trial (Software-aided imaging to increase tumor coverage during ablation), Bruno Odisio, MD, FSIR, The University of Texas MD Anderson Cancer Center, USA
  • iHEPAR Trial (HCC treatment with individualized approach using holmium-166), Marnix Lam, MD, PhD, University Medical Center Utrecht, Netherlands
  • EMERALD-1 (HCC treated with TACE + immune checkpoint blockade), Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center, USA

5:15pm - 6:30pm

Scientific Oral Abstracts & Awards Presentation

Moderators: Alexis Kelekis, MD, PhD, EBIR, FCIRSE, FSIR, National and Kapodistrian University of Athens, Greece; Dimitrios Filippiadis, MD, PhD, MSc, EBIR, University of Athens, Greece

  • Primary Tumor Sidedness, RAS and BRAF Mutations and MSI Status as Prognostic Factors in Patients with Colorectal Liver Metastases: Results from the AmCORE, Madelon Dijkstra, MD, Amsterdam University Medical Centers, VU Medical Center Amsterdam
  • In Situ Vaccination Approach to Treating HCC by Combining Percutaneous Cryoablation With a Plant Virus Nanoparticle Immunoadjuvant, Mansur Ghani, MD, University of California, San Diego, USA
  • Evaluation of LIRADS Treatment Response Criteria in Determining HCC Viability Post Locoregional Therapy in Transplant Patients, Ajay C. Makkena, BS, Thomas Jefferson University, USA
  • Antitumor Efficacy of Transarterial Bland Embolization with Concurrent Everolimus (EveroEmbo) in the Treatment of Hepatic Metastatic Neuroendocrine Tumors, Emad Chishti, BS, University of Kentucky College of Medicine, USA
  • Incidence of Delayed Local Recurrence and Oncological Survival After Thermal Ablation For Early Stage Renal Cell Cancer: A 10-year outcome analysis, Wenhui Zhou, MD, PhD, Stanford University, USA
  • Randomized Trial of Transarterial Chemoembolization With or Without Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma as Bridge to TransplantGregory Nadolski, MD, University of Pennsylvania, USA
  • Augmented Fluoroscopy Guided Transbronchial Pulmonary Microwave Ablation Obviates the Need for a Bronchoscope, Mario Ghosn, MD, Memorial Sloan Kettering Cancer Center, USA

Monday, 28 March 2022

Time (PST)

Session Title(s)

8:30am - 9:30am

Renal

Moderator: David Breen, MD, University Hospital Southampton, UK

  • Indolent Renal Cell Cancer: When to resect, ablate or wait?, Maxwell Meng, MD, UCSF, USA
  • Inheritable Renal Cancer Syndromes, Joyce So, MD, PhD, FRCPC, FCCMG, UCSF, USA
  • Ablation of RCC: Current status, Grant Schmit, MD, Mayo Clinic, USA
  • Awkward RCC Ablation, Brian Welch, MD, Mayo Clinic, USA
  • Loco-regional Treatments for Metastatic RCC, Dimitrios Filippiadis, MD, PhD, MSc, EBIR, University of Athens, Greece
9:30am - 10:30am

Prostate

Moderator: Eric M. Walser, MD, University of Texas Medical Branch, USA

  • Focal Therapy of Prostate: Why, when, how much?, Dan Sperling, MD, DABR, Sperling Prostate Center, USA
  • Focal Therapies: MR- vs. US-guided, Eric M. Walser, MD, University of Texas Medical Branch, USA 
  • Best Energies in Prostate Ablation, David Woodrum, MD, PhD, Mayo Clinic, USA
  • MR/US Fusion-guided HIFU of Prostate Cancer, Afshin Gangi, MD, University Hospital of Strasbourg, France/King's College, UK
  • Prostate Cancer Focal Therapy: Today and tomorrow, TBD
11:00am - 12:00pm

Palliative Care: Multidisciplinary Approach

ModeratorsNicholas Fidelman, MD, UCSF, USA; Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center, USA

  • Symptom Management Service, Michael Rabow, UCSF, USA
  • Nerve Blocks for Pain Palliation, Louis-Martin Boucher, MD, PhD, McGill University, Canada
  • Gastric Decompression, Steven Huang, MD, The University of Texas MD Anderson Cancer Center, USA
  • Advanced Endoscopy Techniques, Jeffrey Chick, MD, MPH, University of Washington, USA
  • Venous Flow Restoration, K. Pallav Kolli, MD, UCSF, USA
12:00pm - 12:15pm

President's Closing Remarks

SIO President, Matthew Callstrom, MD, PhD, Mayo Clinic, USA